Degradation studies demonstrated that HBL‐4 rapidly and with nanomolar potency significantly degraded PLK1 in all AML cell lines tested (DC50 value between 10 and 20 nM).136. This evidence concerns the gene PLK1 and acute myeloid leukemia.